CaMK I is a Ca
2+/calmodulin-dependent kinase positioned downstream of CaMKK, linking intracellular calcium signals to cell-cycle control, neuronal polarity, osteoclast differentiation, and transporter trafficking
[1][2][3][4]. Mechanistically, CaMKK activates CaMKI, CaMKIV, and AMPKα, and CaMKI activity supports Ca
2+-dependent signaling programs in neuronal, metabolic, and pathophysiological pathways
[5]. In hippocampal neurons, TRPC5-dependent localized calcium influx activated CaMKK and CaMKIγ, and CaMKIγ, but not other CaMKI isoforms, promoted axon formation
[2]. Compared with related isoforms, CaMKI regulates G
1, whereas CaMKII regulates G
2/M and the metaphase-anaphase transition, limiting direct extrapolation from CaMKII inhibitor studies to CaMKI biology
[1]. In osteoclast models, CaMKI and CaMKIIγ were present during RANKL-induced differentiation, and KN-93 or KN-62 inhibited osteoclastogenesis, cathepsin K expression, ERK phosphorylation, CREB activity, and bone resorption
[3]. For experimental applications, STO-609-derived TIM-063 directly inhibited CaMKK and suppressed ionomycin-induced phosphorylation of CaMKI, CaMKIV, and AMPKα in cells, supporting pathway-level interrogation rather than CaMKI-selective inhibition
[5].